Correctional Settings

(a)In general. All correctional and detention settings shall make the following information available to both correctional staff and incarcerated individuals:

(1)The importance of emergency opioid antagonists in preventing deaths from opioid overdoses; COL 8/23/2023 CH. 16 THE GUAM OPIOID OVERDOSE PREVENTION ACT OF 2023

(2)How to recognize the signs and symptoms of a drug overdose;

(3)The essential steps in responding to a drug overdose, including:

(A)Evaluate for signs of an opioid overdose;

(B)Call 911 for help;

(C)Administer an emergency opioid antagonist;

(D)Support the person’s breathing; and

(E)Monitor the person’s response.

(4)Where to obtain emergency opioid antagonists throughout Guam;

(5)De-stigmatizing the possession of an emergency opioid antagonist; and

(6)Guam laws limiting a person’s civil and criminal liability for prescribing, distributing, or administering emergency opioid antagonists.

(b)Training. Staff members, employees, and volunteers of Guam correctional settings may take part in training offered pursuant to §16108 of this Act.

(c)Storage. All correctional and detention settings are hereby authorized to possess, stock, dispense, and administer emergency opioid antagonists on their premises and shall keep emergency opioid antagonists in stock pursuant to the prisoner release program established in subsection

(d)of this section.

(d)Risk management officer. All correctional and detention settings shall designate a risk management officer to oversee the possession, stocking, or administration of emergency opioid antagonists on its premises.

(e)Prisoner release. At all correctional and detention settings, on the day of an individual’s release from the correctional or detention setting, correctional and detention staff are required to:

(1)Offer an emergency opioid antagonist; COL 8/23/2023 CH. 16 THE GUAM OPIOID OVERDOSE PREVENTION ACT OF 2023

(2)Provide the individual with instructions on the use of emergency opioid antagonists in the form of a written pamphlet or other accessible instructional materials for an individual with a disability;

(3)Require the individual to sign a written form indicating that they have been give[n] the opportunity to receive an emergency opioid antagonist; and

(4)Provide the individual with information regarding where and how to obtain additional emergency opioid antagonist doses locally.

(f)Amount. When offering an emergency opioid antagonist to a soon-to-be-released incarcerated individual, the individual shall be given as much of the emergency opioid antagonist as they request and is available at the correctional setting.

(g)Purchase agreement. A correctional or detention setting may enter into a purchase agreement with a private entity or organization to purchase a supply of emergency opioid antagonists for use pursuant to this section.